These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1138 related items for PubMed ID: 17257877

  • 1. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC.
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults.
    Aguilar-Betancourt A, González-Delgado CA, Cinza-Estévez Z, Martínez-Cabrera J, Véliz-Ríos G, Alemán-Zaldívar R, Alonso-Martínez MI, Lago-Baños M, Puble-Alvarez N, Delahanty-Fernandez A, Juvier-Madrazo AI, Ortega-León D, Olivera-Ruano L, Correa-Fernández A, Abreu-Reyes D, Soto-Mestre E, Pérez-Pérez MV, Figueroa-Baile N, Pérez LH, Rodríguez-Silva A, Martínez-Díaz E, Guillén-Nieto GE, Muzio-González VL.
    Hum Vaccin; 2008 Sep; 4(1):54-9. PubMed ID: 18441530
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V, Nandakumar S, Shanmugam S, Shankar EM, Thangavel S, Kulkarni PS, Thyagarajan SP.
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF, Morcillo AM, Blotta MH, Da Silva MT, Mazzola TN, Antonio MA, Zanolli ML, Netto AA, Higashi HG, Raw I, Vilela MM.
    Vaccine; 2008 Jan 30; 26(5):647-52. PubMed ID: 18155811
    [Abstract] [Full Text] [Related]

  • 5. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD, Mashinter LD, Lindemulder A, Taylor GD, Chiu I.
    HIV Med; 2007 Jul 30; 8(5):295-9. PubMed ID: 17561875
    [Abstract] [Full Text] [Related]

  • 6. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct 30; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
    Gilbert CL, Klopfer SO, Martin JC, Schödel FP, Bhuyan PK.
    Hum Vaccin; 2011 Dec 30; 7(12):1336-42. PubMed ID: 22185811
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A, Kulkarni PS, Bhave S, Bavdekar A, Naik SS, Pandit AN.
    J Trop Pediatr; 2007 Oct 30; 53(5):303-7. PubMed ID: 17478542
    [Abstract] [Full Text] [Related]

  • 9. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL, Chen YG, Li J, Han GX, Tian C, Liang JL, Li G, Wang ZG, Zhu YG, Tian ZN, Zhang HY, Wan ZJ, Liang ZL, Bi SL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun 30; 25(6):470-3. PubMed ID: 15231119
    [Abstract] [Full Text] [Related]

  • 10. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine.
    Ural O, Findik D.
    J Infect; 2001 Oct 30; 43(3):187-90. PubMed ID: 11798257
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B, Gîlca V, Boulianne N, Deceuninck G, Rochette L, De Serres G.
    Vaccine; 2005 Jul 01; 23(31):4082-7. PubMed ID: 15963363
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.
    Schiff GM, Sherwood JR, Zeldis JB, Krause DS.
    J Adolesc Health; 1995 Jan 01; 16(1):12-7. PubMed ID: 7742331
    [Abstract] [Full Text] [Related]

  • 13. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L, Tian YJ, Shen H, Zhao XP, Yang DL.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 01; 17(4):275-9. PubMed ID: 19403026
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of the effectiveness nine years after primary immunization with local produced plasma-derived hepatitis B vaccine].
    Xu H, Zuo H, Zhuang G.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul 01; 32(4):205-7. PubMed ID: 10322755
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B, Jilg W, Buchholz L, Stremmel W, Engler S.
    Z Gastroenterol; 2003 Oct 01; 41(10):983-90. PubMed ID: 14562195
    [Abstract] [Full Text] [Related]

  • 16. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 01; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W, Muszyńska M, Pawłowska M.
    Med Sci Monit; 2002 Jul 01; 8(7):CR516-9. PubMed ID: 12118201
    [Abstract] [Full Text] [Related]

  • 18. [The immunogenicity and safety of 10 microg recombination yeast hepatitis B vaccine applied in expanded population].
    Fu QP, He H, Li L, Chen HP, Zeng YX, Liu QL, Fang G, Dong CM, Guo SH, Li HG, Wang HY, He CS, Zhou SZ, Li L, Gu SN, Zhang ZF, Dai M.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Oct 01; 43(10):903-6. PubMed ID: 20137473
    [Abstract] [Full Text] [Related]

  • 19. A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine.
    Dupont J, Altclas J, Lepetic A, Lombardo M, Vázquez V, Salgueira C, Seigelchifer M, Arndtz N, Antunez E, von Eschen K, Janowicz Z.
    Vaccine; 2006 Nov 30; 24(49-50):7167-74. PubMed ID: 16884836
    [Abstract] [Full Text] [Related]

  • 20. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
    Raz R, Koren R, Bass D.
    Isr Med Assoc J; 2001 May 30; 3(5):328-32. PubMed ID: 11411195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.